27.07 Bristol-Myers Squibb 17%
II 2013 . Bristol-Myers Squibb 17% 536 . Plavix Avapro/Avalide, FirstWord Pharma. 2013 . 1,541,64 1,411,49 . 16,217,0 16,016,5 . . 2013 . 1,79 . 16,3 . .
Bristol-Myers Squibb II 2013 . 9%, 4 . . 22% 2 . Plavix 94% 44 . 2012 . Avapro/Avalide 52% 56 . 2012 .
Eliquis, BMS Pfizer 2013 . 12 . 22 . I 2013 . 48,3 .
Abilify 21% 563 . .
